These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16145253)

  • 21. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes: response to Kahn et al.
    Cheţa DM
    Diabetes Care; 2006 Jan; 29(1):176-7; author reply 177-8. PubMed ID: 16419354
    [No Abstract]   [Full Text] [Related]  

  • 22. Insulin-mediated sympathoexcitation in obesity and type 2 diabetes.
    Muntzel MS
    Nephrol Dial Transplant; 1999 Oct; 14(10):2282-5. PubMed ID: 10528643
    [No Abstract]   [Full Text] [Related]  

  • 23. Metabolic syndrome: definition, pathophysiology, and mechanisms.
    Miranda PJ; DeFronzo RA; Califf RM; Guyton JR
    Am Heart J; 2005 Jan; 149(1):33-45. PubMed ID: 15660032
    [No Abstract]   [Full Text] [Related]  

  • 24. Molecular Mechanisms of Sodium-Sensitive Hypertension in the Metabolic Syndrome.
    Nizar JM; Bhalla V
    Curr Hypertens Rep; 2017 Aug; 19(8):60. PubMed ID: 28676941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sympathetic nerve activity in metabolic control--some basic concepts.
    Fagius J
    Acta Physiol Scand; 2003 Mar; 177(3):337-43. PubMed ID: 12609004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle.
    Nair S; Lee YH; Lindsay RS; Walker BR; Tataranni PA; Bogardus C; Baier LJ; Permana PA
    Diabetologia; 2004 Jun; 47(6):1088-95. PubMed ID: 15156315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of the sympathetic adrenal system in the pathogenesis of the insulin resistance syndrome.
    Landsberg L
    Ann N Y Acad Sci; 1999 Nov; 892():84-90. PubMed ID: 10842654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin resistance and the metabolic syndrome.
    Lann D; Gallagher E; Leroith D
    Minerva Med; 2008 Jun; 99(3):253-62. PubMed ID: 18497723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of sleep disturbances with obesity, insulin resistance and the metabolic syndrome.
    Koren D; Taveras EM
    Metabolism; 2018 Jul; 84():67-75. PubMed ID: 29630921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting 11β-hydroxysteroid dehydrogenases: a novel approach to manipulating local glucocorticoid levels with implications for rheumatic disease.
    Hardy RS; Seibel MJ; Cooper MS
    Curr Opin Pharmacol; 2013 Jun; 13(3):440-4. PubMed ID: 23540586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome in childhood - causes and effects.
    Weiss R
    Endocr Dev; 2010; 19():62-72. PubMed ID: 20551669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Components of the "metabolic syndrome" and incidence of type 2 diabetes.
    Hanson RL; Imperatore G; Bennett PH; Knowler WC
    Diabetes; 2002 Oct; 51(10):3120-7. PubMed ID: 12351457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the pathophysiology of obesity-associated cardiovascular disease.
    Eckel RH; Barouch WW; Ershow AG
    Circulation; 2002 Jun; 105(24):2923-8. PubMed ID: 12070124
    [No Abstract]   [Full Text] [Related]  

  • 34. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
    Morton NM; Seckl JR
    Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperinsulinemic syndrome: the metabolic syndrome is broader than you think.
    Kelly CT; Mansoor J; Dohm GL; Chapman WH; Pender JR; Pories WJ
    Surgery; 2014 Aug; 156(2):405-11. PubMed ID: 24962189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 6th Annual World Congress on the insulin resistance syndrome.
    Bloomgarden ZT
    Diabetes Care; 2009 Sep; 32(9):e104-11. PubMed ID: 19717816
    [No Abstract]   [Full Text] [Related]  

  • 37. Redox implications in adipose tissue (dys)function--A new look at old acquaintances.
    Jankovic A; Korac A; Buzadzic B; Otasevic V; Stancic A; Daiber A; Korac B
    Redox Biol; 2015 Dec; 6():19-32. PubMed ID: 26177468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin resistance syndrome: a marker for increased risk of coronary heart disease in Asian Indians.
    Dhawan J
    Indian Heart J; 1996; 48(4):355-6. PubMed ID: 8908819
    [No Abstract]   [Full Text] [Related]  

  • 39. Is metabolic syndrome X an inflammatory condition?
    Das UN
    Exp Biol Med (Maywood); 2002 Dec; 227(11):989-97. PubMed ID: 12486208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The metabolic syndrome X and peripheral cortisol synthesis.
    Bähr V; Pfeiffer AF; Diederich S
    Exp Clin Endocrinol Diabetes; 2002 Oct; 110(7):313-8. PubMed ID: 12397528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.